The South African Tuberculosis Vaccine Initiative will be offering a limited number of bursaries to cover the Registration Fees associated with the SciMathUS Program, a university preparation program which is offered by the Stellenbosch University...
Community Engagement
In March 2016 SATVI brought "Lienkie se Longe", a drama to raise awareness about TB, to the Worcester Easter Festival. The drama tells the story of Lienkie, whose lungs “talk with each other’ about their health and the health of Lienkie’s boyfriend...
Biomarker discovery offers hope for new TB vaccine development
A team of scientists from the University of Cape Town, Oxford University and the London School of Hygiene & Tropical Medicine have made a discovery that reveals how we can improve development of more effective vaccines against tuberculosis.
Community Engagement
In 2012 SATVI developed a drama production to promote awareness about TB vaccine clinical research, titled “Carina’s Choice” with learners from Worcester Secondary School as actors and UCT drama school students as mentors. A very successful roadshow...
Accredited UCT Research Centre
The South African Tuberculosis Vaccine Initiative (SATVI) is an accreditated Research Centre of the University of Cape Town.


Thursday, 22 February 2018
19 February 2018 Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines

NEW DELHI, 19 FEBRUARY 2018    -   Scientists from the University of Cape Town-based South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced the findings of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. The results were presented at the 5th Global Forum on TB Vaccines in New Delhi, India 20-23 February 2018.

Publication Date:
Monday, February 19, 2018 - 20:00
Vacancy Research Pharmacist

We have a vacancy for a Research Pharmacist at our Worcester Field site. NOW CLOSED

Publication Date:
Tuesday, November 21, 2017 - 12:15
New Gobal commitment to end TB

On Friday 17 November 75 ministers announced a landmark agreement to take urgent action to end tuberculosis (TB) by 2030 at the conclusion of a World Health Organization (WHO) conference in Moscow, Russia, on eradicating the world's deadliest infectious disease.

Publication Date:
Monday, November 20, 2017 - 08:30
9 November 2017 Research Published: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

Associate Professor Tom Scriba has collaborated with the authors of a research paper titled: "TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development" appearing in the Frontiers in Immunology Journal.

Publication Date:
Thursday, November 9, 2017 - 14:15